BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28531231)

  • 21. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
    Wang T; Tan YJ; Wu SJ; Huang M; Yin BT; Huang J; Wei N; Wei W; Wang F
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):262-267. PubMed ID: 30955283
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection.
    Balcells ME; Ruiz-Tagle C; Tiznado C; García P; Naves R
    Tuberculosis (Edinb); 2018 Sep; 112():110-119. PubMed ID: 30205963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
    J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Tang G; Lin Q; Mao L; Xue Y; Yuan X; Ouyang R; Wu S; Yu J; Zhou Y; Liu W; Hou H; Wang F; Sun Z
    J Infect; 2020 Jul; 81(1):81-89. PubMed ID: 32360883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
    Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
    Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a New IFN-γ Release Assay for Rapid Diagnosis of Active Tuberculosis in a High-Incidence Setting.
    Li G; Li F; Zhao HM; Wen HL; Li HC; Li CL; Ji P; Xu P; Wu K; Hu ZD; Lu SH; Lowrie DB; Lv JX; Fan XY
    Front Cell Infect Microbiol; 2017; 7():117. PubMed ID: 28443247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
    Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
    Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
    Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
    Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis.
    Zhou Y; Zhang F; Shi H; Wu P; Zhou Y
    Tuberculosis (Edinb); 2022 Sep; 136():102256. PubMed ID: 36113397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined IFN-γ and TNF-α release assay for differentiating active tuberculosis from latent tuberculosis infection.
    Kim JY; Park JH; Kim MC; Cha HH; Jeon NY; Park SY; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Infect; 2018 Oct; 77(4):314-320. PubMed ID: 29746954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
    Chiappini E; Della Bella C; Bonsignori F; Sollai S; Amedei A; Galli L; Niccolai E; Del Prete G; Singh M; D'Elios MM; de Martino M
    PLoS One; 2012; 7(9):e46041. PubMed ID: 23029377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An IFN-γ and TNF-α dual release fluorospot assay for diagnosing active tuberculosis.
    Kim JY; Kang YA; Park JH; Cha HH; Jeon NY; Lee SW; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Clin Microbiol Infect; 2020 Jul; 26(7):928-934. PubMed ID: 31730906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Mycobacterium tuberculosis-specific antibody responses for the discrimination of active and latent tuberculosis infection.
    Wang S; Wu J; Chen J; Gao Y; Zhang S; Zhou Z; Huang H; Shao L; Jin J; Zhang Y; Zhang W
    Int J Infect Dis; 2018 May; 70():1-9. PubMed ID: 29410147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active Tuberculosis Is Characterized by Highly Differentiated Effector Memory Th1 Cells.
    Arrigucci R; Lakehal K; Vir P; Handler D; Davidow AL; Herrera R; Estrada-Guzmán JD; Bushkin Y; Tyagi S; Lardizabal AA; Gennaro ML
    Front Immunol; 2018; 9():2127. PubMed ID: 30283456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB.
    Marín ND; París SC; Rojas M; García LF
    Tuberculosis (Edinb); 2013 Mar; 93(2):155-66. PubMed ID: 23332142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study.
    Gourgouillon N; de Lauzanne A; Cottart CH; Curis E; Debord C; Guérin-El Khourouj V; Pédron B; Faye A; Sterkers G
    Pediatr Res; 2012 Oct; 72(4):370-4. PubMed ID: 22797138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.